Trial · NCT00559988
Results by group34
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 34
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Composite Primary Endpoint: Kaplan-Meier Estimate of Patients Without a Stroke, Systemic Embolism, or Major Bleed | Home Monitoring Guided OAC | Kaplan-Meier estimate at 1 Year | 97.5 | percentage of participants-Kaplan Meier | |
| Composite Primary Endpoint: Kaplan-Meier Estimate of Patients Without a Stroke, Systemic Embolism, or Major Bleed | Physician-Directed OAC | Kaplan-Meier estimate at 1 Year | 97.7 | percentage of participants-Kaplan Meier | |
| Composite Primary Endpoint: Kaplan-Meier Estimate of Patients Without a Stroke, Systemic Embolism, or Major Bleed | Home Monitoring Guided OAC | Kaplan-Meier estimate at 2 Years | 94.8 | percentage of participants-Kaplan Meier | |
| Composite Primary Endpoint: Kaplan-Meier Estimate of Patients Without a Stroke, Systemic Embolism, or Major Bleed | Physician-Directed OAC | Kaplan-Meier estimate at 2 Years | 95.7 | percentage of participants-Kaplan Meier | |
| Composite Primary Endpoint: Kaplan-Meier Estimate of Patients Without a Stroke, Systemic Embolism, or Major Bleed | Home Monitoring Guided OAC | Kaplan-Meier estimate at 3 Years | 92.3 | percentage of participants-Kaplan Meier | |
| Composite Primary Endpoint: Kaplan-Meier Estimate of Patients Without a Stroke, Systemic Embolism, or Major Bleed | Physician-Directed OAC | Kaplan-Meier estimate at 3 Years | 92.0 | percentage of participants-Kaplan Meier | |
| Composite Primary Endpoint: Kaplan-Meier Estimate of Patients Without a Stroke, Systemic Embolism, or Major Bleed | Home Monitoring Guided OAC | Kaplan-Meier estimate at 4 Years | 90.0 | percentage of participants-Kaplan Meier | |
| Composite Primary Endpoint: Kaplan-Meier Estimate of Patients Without a Stroke, Systemic Embolism, or Major Bleed | Physician-Directed OAC | Kaplan-Meier estimate at 4 Years | 89.4 | percentage of participants-Kaplan Meier | |
| Composite Primary Endpoint: Kaplan-Meier Estimate of Patients Without a Stroke, Systemic Embolism, or Major Bleed | Home Monitoring Guided OAC | Kaplan-Meier estimate at 5 Years | 86.8 | percentage of participants-Kaplan Meier | |
| Composite Primary Endpoint: Kaplan-Meier Estimate of Patients Without a Stroke, Systemic Embolism, or Major Bleed | Physician-Directed OAC | Kaplan-Meier estimate at 5 Years | 87.9 | percentage of participants-Kaplan Meier | |
| Rates of All-cause Mortality | Home Monitoring Guided OAC | 147 | Participants | ||
| Rates of All-cause Mortality | Physician-Directed OAC | 140 | Participants | ||
| Rate of Ischemic and Hemorrhagic Stroke | Home Monitoring Guided OAC | Ischemic stroke | 22 | Participants | |
| Rate of Ischemic and Hemorrhagic Stroke | Physician-Directed OAC | Ischemic stroke | 28 | Participants | |
| Rate of Ischemic and Hemorrhagic Stroke | Home Monitoring Guided OAC | Hemorrhagic stroke | 3 | Participants | |
| Rate of Ischemic and Hemorrhagic Stroke | Physician-Directed OAC | Hemorrhagic stroke | 3 | Participants | |
| Rate of Fatal or Disabling and Non-disabling Stroke | Home Monitoring Guided OAC | Fatal or disabling stroke | 9 | Participants | |
| Rate of Fatal or Disabling and Non-disabling Stroke | Physician-Directed OAC | Fatal or disabling stroke | 11 | Participants | |
| Rate of Fatal or Disabling and Non-disabling Stroke | Home Monitoring Guided OAC | Non-disabling stroke | 15 | Participants | |
| Rate of Fatal or Disabling and Non-disabling Stroke | Physician-Directed OAC | Non-disabling stroke | 19 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00559988/results